71 results
Page 2 of 4
8-K
EX-99.1
36hwat55lwd lo8
14 Aug 23
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023
7:06am
DEFA14A
l81mt
23 May 23
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
qfvsmmru3 5l
12 May 23
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2023
7:04am
8-K
EX-99.1
m9tzmhzd3s285r n5n
30 Mar 23
Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022
7:19am
8-K
EX-99.2
vpfca
12 Dec 22
Regulation FD Disclosure
6:37am
8-K
z78 83bl2pt
12 Dec 22
Regulation FD Disclosure
6:37am
8-K
EX-99.1
kn59vo q08l962a
12 Dec 22
Regulation FD Disclosure
6:37am
8-K
EX-99.1
ftk 4wdlqh9su7j3o
10 Nov 22
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2022
7:04am
8-K
EX-99.1
tjp3ipf ufbz
10 Aug 22
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2022; Provides Program Update for ZF874
12:00am
S-3
je9fectxsbp
1 Jul 22
Shelf registration
4:06pm
DEFA14A
c3njklqn
9 Jun 22
Additional proxy soliciting materials
9:06am
8-K
EX-99.2
5zq7cznrd0j fnsm
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
DEF 14A
4z7w3zt8
23 May 22
Definitive proxy
8:00am